Blackrock Neurotech is the longest-established intracortical BCI company, with the Utah Array having accumulated more documented long-term human implant data than any competing device in the field. Its Series B funding and FDA Breakthrough Designation position it as the reference platform against which newer implantable BCI entrants are benchmarked, though it faces increasing competitive pressure from companies pursuing less invasive approaches.